HHS sends White House a plan letting pharmacies compound peptides like BPC-157
Two people familiar with the plan say the FDA would hold back enforcement on certain popular peptides, even though its own scientists said none were studied enough.
Recap by typeshit. Full story at Northwest Arkansas Democrat-Gazette.